EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Optimal sample size allocation for two‐arm superiority and non‐inferiority trials with binary endpoints

Marietta Kirchner iD, Stefanie Schüpke iD, Meinhard Kieser iD

Pharmaceutical Statistics · 2024

DOI: 10.1002/pst.2375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2024. Verfasst von Marietta Kirchner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Equivalence Trials as Topic, Research Design, Endpoint Determination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sample size of a clinical trial has to be large enough to ensure sufficient power for achieving the aim the study. On the other side, for ethical and economical reasons it should not be larger than necessary. The sample size allocation is one of the parameters that influences the required total sample size. For two‐arm superiority and non‐inferiority trials with binary endpoints, we performed extensive computations over a wide range of scenarios to determine the optimal allocation ratio that minimizes the total sample size if all other parameters are fixed. The results demonstrate, that for both superiority and non‐inferiority trials the optimal allocation may deviate considerably from the case of equal sample size in both groups. However, the saving in sample size when allocating the total sample size optimally as compared to balanced allocation is typically small.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Equivalence Trials as TopicResearch DesignEndpoint DeterminationSample SizeHumansClinical Trials as Topic

Stichwörter der Autor:innen

allocation ratioclinical trialpowersample size

Autor:innen und Institutionen

  • Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
  • Privatpraxis für Kardiologie, Frankfurt am Main, Germany.
  • Deutsches Herzzentrum München, ISAResearch Center, München, Germany.
  • DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Berlin, Germany.

ORCID-Profile: Marietta Kirchner, Stefanie Schüpke, Meinhard Kieser

Zitieren

APA

Kirchner, M., Schüpke, S., & Kieser, M. (2024). Optimal sample size allocation for two‐arm superiority and non‐inferiority trials with binary endpoints. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2375

Vancouver

Kirchner M, Schüpke S, Kieser M. Optimal sample size allocation for two‐arm superiority and non‐inferiority trials with binary endpoints. Pharmaceutical Statistics. 2024. doi:10.1002/pst.2375

BibTeX
@article{Kirchner2024,
  author = {Kirchner, Marietta and Schüpke, Stefanie and Kieser, Meinhard},
  title = {Optimal sample size allocation for two‐arm superiority and non‐inferiority trials with binary endpoints},
  journal = {Pharmaceutical Statistics},
  year = {2024},
  doi = {10.1002/pst.2375}
}
Kostenlos starten →